公开(公告)号：US4808629A

公开(公告)日：1989-02-28

申请号：US62073

申请日：1987-05-14

申请人： Yaguang Liu

发明人： Yaguang Liu

IPC分类号： A61K31/015 ,  A61K31/19 ,  A61K36/13 ,  A61K36/235 ,  A61K36/258 ,  A61K36/51 ,  A61K36/638

CPC分类号： A61K36/13 ,  A61K36/235 ,  A61K36/258 ,  A61K36/51 ,  A61K36/638 ,  Y10S514/885

摘要： A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.

摘要翻译： 一种用于治疗非淋巴性白血病的新型药物组合物，例如包括Harringtonine，Homoharringtonine，Anethole，Oleanolic acid和人参皂苷的粒细胞和单核细胞白血病及其制备方法。

公开(公告)号：US4783454A

公开(公告)日：1988-11-08

申请号：US50852

申请日：1987-05-14

申请人： Yaguang Liu

发明人： Yaguang Liu

IPC分类号： A61K31/55 ,  A61K36/13 ,  A61K36/23 ,  A61K36/235 ,  A61K36/24 ,  A61K36/51 ,  A61K36/638

CPC分类号： A61K36/235 ,  A61K36/13 ,  A61K36/23 ,  A61K36/24 ,  A61K36/51 ,  A61K36/638 ,  Y10S514/908

摘要： A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.

摘要翻译： 一种用于治疗非淋巴性白血病的新型药物组合物，例如包括Harringtonine，Homoharringtonine，Anethole，Oleanolic acid和人参皂苷的粒细胞和单核细胞白血病及其制备方法。

公开(公告)号：US20240081375A1

公开(公告)日：2024-03-14

申请号：US18274673

申请日：2022-01-14

申请人： Xia ZHANG

发明人： Xia ZHANG ,  Chuyue ZHANG ,  Yao ZHANG ,  Le KANG

IPC分类号： A23K10/30 ,  A23K50/10 ,  A61K36/185 ,  A61K36/21 ,  A61K36/232 ,  A61K36/235 ,  A61K36/315 ,  A61K36/42 ,  A61K36/484 ,  A61K36/52 ,  A61K36/53 ,  A61K36/539 ,  A61K36/575 ,  A61K36/61 ,  A61K36/67 ,  A61K36/734 ,  A61K36/752 ,  A61K36/758 ,  A61K36/8962 ,  A61K36/9064 ,  A61K36/9068 ,  A61P43/00

CPC分类号： A23K10/30 ,  A23K50/10 ,  A61K36/185 ,  A61K36/21 ,  A61K36/232 ,  A61K36/235 ,  A61K36/315 ,  A61K36/42 ,  A61K36/484 ,  A61K36/52 ,  A61K36/53 ,  A61K36/539 ,  A61K36/575 ,  A61K36/61 ,  A61K36/67 ,  A61K36/734 ,  A61K36/752 ,  A61K36/758 ,  A61K36/8962 ,  A61K36/9064 ,  A61K36/9068 ,  A61P43/00

摘要： A microbial Chinese herbal medicine feed having effects of detoxication, muttony odor removal, flavor enhancement and mutton quality improvement, comprising 190-1920 parts of feed substrate, 39-238 parts of additives, 1-65 parts of Chinese herbal medicine components, and 100-550 parts of forage powder; the Chinese herbal medicine components comprise fructus aurantii, dried tangerine peel, Amomum villosum and so on. The formula of the invention can obviously decrease the synthesis of short-chain fatty acids and C18 fatty acids in sheep, inhibit and block the further combination of C6, C8 and C10 into stable complexes or associations to the greatest extent and effectively improve the quality of the mutton, particularly effective in removing odor of the mutton.

公开(公告)号：US20230321248A1

公开(公告)日：2023-10-12

申请号：US18201375

申请日：2023-05-24

申请人： GENAXA INC.

发明人： Max Spielberg ,  David Johnson

IPC分类号： A61K35/644 ,  A61K36/736 ,  A61K36/235 ,  A61K47/26 ,  A61K31/167 ,  A61K47/46 ,  A61K36/35 ,  A61K47/12 ,  A61K9/00 ,  A61K36/88 ,  A61K36/9068 ,  A61K36/9066 ,  A61P11/14 ,  A61K36/074

CPC分类号： A61K47/46 ,  A61K9/0053 ,  A61K9/0095 ,  A61K31/167 ,  A61K35/644 ,  A61K36/074 ,  A61K36/235 ,  A61K36/35 ,  A61K36/736 ,  A61K36/88 ,  A61K36/9066 ,  A61K36/9068 ,  A61K47/12 ,  A61K47/26 ,  A61P11/14

摘要： A stable pharmaceutical formulation or suspension has acetaminophen, a suspension agent, and a diluent. The formulation or suspension has viscosity suitable for drinking.

公开(公告)号：US11717552B2

公开(公告)日：2023-08-08

申请号：US16345844

申请日：2017-11-01

申请人： ALPHANOSOS S.A.S.

发明人： Pascal Mayer ,  Laure Breuils

IPC分类号： A61K36/87 ,  A23L33/10 ,  A23L33/105 ,  A61P31/04 ,  A61K36/03 ,  A61K36/04 ,  A61K36/14 ,  A61K36/235 ,  A61K36/28 ,  A61K36/45 ,  A61K36/48 ,  A61K36/534 ,  A61K36/61 ,  A61K36/708 ,  A61K36/73 ,  A61K36/74 ,  A61K36/82 ,  A61K36/84 ,  A61K36/85 ,  A61K8/97

CPC分类号： A61K36/87 ,  A23L33/105 ,  A23L33/127 ,  A61K36/03 ,  A61K36/04 ,  A61K36/14 ,  A61K36/235 ,  A61K36/28 ,  A61K36/45 ,  A61K36/48 ,  A61K36/534 ,  A61K36/61 ,  A61K36/708 ,  A61K36/73 ,  A61K36/74 ,  A61K36/82 ,  A61K36/84 ,  A61K36/85 ,  A61P31/04 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2250/21 ,  A61K8/97 ,  A61K2236/30 ,  A61K2236/51 ,  Y02A50/30 ,  A61K36/82 ,  A61K2300/00 ,  A61K36/87 ,  A61K2300/00 ,  A61K36/45 ,  A61K2300/00 ,  A61K36/61 ,  A61K2300/00 ,  A61K36/73 ,  A61K2300/00 ,  A61K36/48 ,  A61K2300/00

摘要： An extract of an herbal composition comprising at least two different dried plants useful as antimicrobial and/or antibiofilm agent in the treatment or prevention of microbial infections caused by bacteria, such as for example Escherichia, Klebsiella, Listeria, Pseudomonas, Salmonella, Streptococcus or Staphylococcus, or by fungi, such as for example is herein described. It has been found that in such extract, the active ingredients exert their biological effects in a synergistic manner. The extract may constitute the active ingredient of a food supplement, a nutraceutical, pharmaceutical or cosmetic composition or a functional food or a food additive. A process for preparing said extract is also described here.

公开(公告)号：US20230233637A1

公开(公告)日：2023-07-27

申请号：US18129182

申请日：2023-03-31

申请人： Akrivista LLC

发明人： Scott Whitcup ,  Orest Olejnik ,  Michael Garst ,  Peter Simmons

IPC分类号： A61K36/235 ,  A61P27/04 ,  A61K9/00 ,  A61K36/534 ,  A61K36/61 ,  G01N33/50 ,  A61K36/54 ,  A61K36/752 ,  A61K47/32 ,  A61K9/107 ,  A61K36/47 ,  A61K47/44

CPC分类号： A61K36/235 ,  A61P27/04 ,  A61K9/0048 ,  A61K36/534 ,  A61K36/61 ,  G01N33/50 ,  A61K36/54 ,  A61K36/752 ,  A61K47/32 ,  A61K9/1075 ,  A61K36/47 ,  A61K47/44

摘要： In preferred embodiments the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil.

公开(公告)号：US20190160010A1

公开(公告)日：2019-05-30

申请号：US15878374

申请日：2018-01-23

申请人： Zhonghua CI

发明人： Zhonghua CI

IPC分类号： A61K9/16 ,  A61K36/076 ,  A61K36/535 ,  A61K36/815 ,  A61K36/73 ,  A61K36/54 ,  A61K36/235 ,  A61K36/9068 ,  A61K9/00 ,  A23L2/02 ,  A23L2/60 ,  A23L29/212

CPC分类号： A61K9/1682 ,  A23L2/02 ,  A23L2/08 ,  A23L2/39 ,  A23L2/60 ,  A23L29/212 ,  A23V2002/00 ,  A61K9/0095 ,  A61K9/1617 ,  A61K9/1652 ,  A61K36/076 ,  A61K36/235 ,  A61K36/535 ,  A61K36/54 ,  A61K36/73 ,  A61K36/815 ,  A61K36/9068 ,  A23V2250/2482 ,  A23V2250/5114 ,  A23V2250/5118 ,  A61K2300/00

摘要： Provided is a solid drink for regulating yang-deficiency constitution. The solid drink includes the following components of raw materials in parts by weight: perilla 30-60, raspberry 35-55, lycium barbarum 35-57, poria 30-54, cinnamon 35-55, fennel 20-40, ginger 33-55, dextrin 50-90, maltodextrin 23-45, soluble starch 20-44, and aspartame 0.15-0.35. The solid drink is easy to manufacture, and all the raw materials used are medicine materials of medicinal and edible dual purposes, and all the excipients used also satisfy national standard GB2760-2011 (National Food Safety Standard for Uses of Food Additives). It is safe to eat (drink) with good taste, and long-term consumption has certain effects on improving the yang-deficiency constitution. Moreover, the processing process is suitable for industrial mass production.

公开(公告)号：US20180000864A1

公开(公告)日：2018-01-04

申请号：US15545010

申请日：2015-12-10

申请人： Jacqueline COURTIOL ,  Timothy LAWRENCE

发明人： Jacqueline COURTIOL ,  Timothy LAWRENCE

IPC分类号： A61K33/44 ,  A61K47/10 ,  A61K36/9068 ,  A61K36/886 ,  A61K36/534 ,  A61K36/53 ,  A61K36/28 ,  A61K36/235 ,  A61K36/185 ,  A61K47/12 ,  A61K9/10

CPC分类号： A61K33/44 ,  A61K9/10 ,  A61K36/185 ,  A61K36/235 ,  A61K36/28 ,  A61K36/53 ,  A61K36/534 ,  A61K36/886 ,  A61K36/9068 ,  A61K41/0004 ,  A61K47/10 ,  A61K47/12 ,  A61K2300/00

摘要： The present invention generally relates to homeopathic compositions, and, more particularly, (i) homeopathic compositions comprising a homeopathically potentised form of Passiflora incarnata (Passionflower), and a homeopathically potentised form of Nux Moschata (Nutmeg); or (ii) a homeopathically potentised Carbo Vegetabilis; and a homeopathically potentised Passiflora incarnata; or (iii) a homeopathically potentised Carbo Vegetabilis; and a homeopathically potentised Nux Moschata; and methods of treatment using these homeopathic compositions.

公开(公告)号：US20180000107A1

公开(公告)日：2018-01-04

申请号：US15703219

申请日：2017-09-13

申请人： Samah Bensalem

发明人： Samah Bensalem

IPC分类号： A23F3/00 ,  A23L33/105 ,  A61K36/28 ,  A61K36/235 ,  A61K9/00

CPC分类号： A23F3/00 ,  A23F3/34 ,  A23F2200/00 ,  A23L27/10 ,  A23L33/105 ,  A61K9/0095 ,  A61K36/23 ,  A61K36/235 ,  A61K36/28 ,  A61K2300/00

摘要： Herbal tea compositions that, when consumed as a beverage by babies, eases common baby digestive discomforts and helps babies to sleep and feel better. The compositions comprise fennel seed, cumin seed. Some blends additionally contain dried chamomile flower.

公开(公告)号：US20170136061A1

公开(公告)日：2017-05-18

申请号：US14620986

申请日：2015-02-12

申请人： Victor Ortega

发明人： Victor Ortega

IPC分类号： A61K33/10 ,  A61K38/43 ,  A61K36/484 ,  A61K36/906 ,  A61K31/198 ,  A61K31/015 ,  A61K45/06 ,  A61K31/555 ,  A61K36/886 ,  A61K36/73 ,  A61K36/235 ,  A61K36/28 ,  A61K36/54 ,  A61K31/352 ,  A61K38/39 ,  A61K31/05 ,  A61K35/745 ,  A61K35/747 ,  A61K33/00

CPC分类号： A61K33/10 ,  A61K31/015 ,  A61K31/05 ,  A61K31/198 ,  A61K31/352 ,  A61K31/555 ,  A61K33/00 ,  A61K33/30 ,  A61K35/745 ,  A61K35/747 ,  A61K36/185 ,  A61K36/235 ,  A61K36/28 ,  A61K36/484 ,  A61K36/54 ,  A61K36/73 ,  A61K36/886 ,  A61K36/906 ,  A61K36/9068 ,  A61K38/39 ,  A61K38/43 ,  A61K38/4873 ,  A61K45/06 ,  A61K2035/115 ,  A61K2300/00

摘要： A supplemented antacid formulation comprising at least one primary component and at least one supplemental component. In one embodiment, a primary component is selected from the group consisting of calcium carbonate, magnesium carbonate, and potassium bicarbonate, and a supplemental component is selected from the group consisting of L-glutamine, deglycyrrhizinated licorice, D-limonene, papain, ginger extract, zinc L-carnosine complex, and a probiotic blend. In one further embodiment, a supplemented antacid formulation comprises a plurality of primary components in combination with a plurality of supplemental components, wherein the primary components are selected from the group consisting of calcium carbonate, magnesium carbonate, and potassium bicarbonate, and the supplemental components are selected from the group consisting of L-glutamine, deglycyrrhizinated licorice, D-limonene, papain, ginger extract, zinc L-carnosine complex, and a probiotic blend.